{
    "Trade/Device Name(s)": [
        "Enterix\u00ae InSure\u00ae FIT\u2122 FOBT Controls"
    ],
    "Submitter Information": "Bionostics, Inc.",
    "510(k) Number": "K101831",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041297",
        "K080812"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OSL"
    ],
    "Summary Letter Date": "October 1, 2010",
    "Summary Letter Received Date": "August 24, 2010",
    "Submission Date": "August 18, 2010",
    "Regulation Number(s)": [
        "21 CFR 864.6550"
    ],
    "Regulation Name(s)": [
        "Occult blood test"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "hemoglobin"
    ],
    "Specimen Type(s)": [
        "Fecal occult blood test control solution"
    ],
    "Specimen Container(s)": [
        "3 mL plastic dropper vial"
    ],
    "Instrument(s)/Platform(s)": [
        "Enterix InSure FIT product"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay (as used in FIT test)"
    ],
    "Methodologies": [
        "Qualitative control testing"
    ],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Enterix InSure FIT FOBT Controls, a two-level quality control solution for fecal immunochemical test systems.",
    "Indications for Use Summary": "For in vitro diagnostic use as assayed positive and negative controls to independently verify the functionality and performance of the Enterix InSure FIT product in clinical laboratories.",
    "fda_folder": "Hematology"
}